Your browser doesn't support javascript.
loading
SARS-CoV-2 show no infectivity at later stages in a prolonged COVID-19 patient despite positivity in RNA testing.
Wan, Xiu-Feng; Tang, Cynthia Y; Ritter, Detlef; Wang, Yang; Li, Tao; Segovia, Karen; Kosikova, Martina; Johnson, Marc; Kwon, Hyung J; Xie, Hang; Hammer, Richard D; McElroy, Jane A; Hamid, Aws; Collins, Natalie D; Hang, Jun; Camp, Simone.
Afiliação
  • Wan XF; MU Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, Missouri, USA.
  • Tang CY; Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA.
  • Ritter D; Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA.
  • Wang Y; Department of Electrical Engineering & Computer Science, College of Engineering, University of Missouri, Columbia, Missouri, USA.
  • Li T; MU Institute for Data Science and Informatics, University of Missouri, Columbia, Missouri, USA.
  • Segovia K; MU Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, Missouri, USA.
  • Kosikova M; Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA.
  • Johnson M; Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA.
  • Kwon HJ; MU Institute for Data Science and Informatics, University of Missouri, Columbia, Missouri, USA.
  • Xie H; Department of Pathology, University of Missouri, Columbia, Missouri, USA.
  • Hammer RD; MU Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, Missouri, USA.
  • McElroy JA; Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA.
  • Hamid A; Bond Life Sciences Center, University of Missouri, Columbia, Missouri, USA.
  • Collins ND; Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
  • Hang J; MU Center for Influenza and Emerging Infectious Diseases, University of Missouri, Columbia, Missouri, USA.
  • Camp S; Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, Missouri, USA.
J Med Virol ; 93(7): 4570-4575, 2021 07.
Article em En | MEDLINE | ID: mdl-33830520

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eliminação de Partículas Virais / Anticorpos Neutralizantes / Teste de Ácido Nucleico para COVID-19 / COVID-19 / Anticorpos Antivirais Limite: Aged / Humans / Male Idioma: En Revista: J Med Virol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eliminação de Partículas Virais / Anticorpos Neutralizantes / Teste de Ácido Nucleico para COVID-19 / COVID-19 / Anticorpos Antivirais Limite: Aged / Humans / Male Idioma: En Revista: J Med Virol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos